Literature DB >> 10987322

Doppler microembolic signals predict ischemic recurrences in symptomatic carotid stenosis.

B Censori1, T Partziguian, L Casto, M Camerlingo, A Mamoli.   

Abstract

OBJECTIVE: To assess if Doppler microembolic signals (MES) associated with > or = 60% symptomatic extracranial carotid stenosis may predict ischemic recurrences before endarterectomy or angioplasty.
METHODS: All patients with > or = 60% carotid stenosis with symptoms in the preceding 2 months were prospectively considered. MES were identified using current criteria. All patients were followed-up until endarterectomy or angioplasty.
RESULTS: We studied 50 patients, at a median of 7 days from their last symptom. Twenty patients showed MES (40.0%); median embolus rate was 4/h. During a median follow-up of 19 days 7 patients had recurrences (transient monocular blindness = 2; TIAs=4; stroke=1); 6 of them had shown MES. The association between recurrences and MES was significant (P=0.012).
CONCLUSIONS: MES may identify patients with symptomatic carotid stenosis who are likely to suffer an ischemic recurrence before endarterectomy. This information may affect medical treatment and referral to the vascular surgeon.

Entities:  

Mesh:

Year:  2000        PMID: 10987322     DOI: 10.1034/j.1600-0404.2000.90342a.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  2 in total

Review 1.  Prevalence and prognostic impact of microembolic signals in arterial sources of embolism. A systematic review of the literature.

Authors:  Martin A Ritter; Ralf Dittrich; Niels Thoenissen; E Bernd Ringelstein; Darius G Nabavi
Journal:  J Neurol       Date:  2008-05-06       Impact factor: 4.849

2.  Microemboli After Successful Thrombectomy Do Not Affect Outcome but Predict New Embolic Events.

Authors:  Faheem Sheriff; Mariana Diz-Lopes; Ayaz Khawaja; Farzaneh Sorond; Can Ozan Tan; Elsa Azevedo; Maria Angela Franceschini; Henri Vaitkevicius; Karen Li; Andrew Donald Monk; Sarah LaRose Michaud; Steven K Feske; Pedro Castro
Journal:  Stroke       Date:  2019-12-04       Impact factor: 7.914

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.